Pharmerica charged by Justice Department for violating Controlled Substances Act; filing false Medicare claims

The Justice Department has filed suit against PharMerica (PMC -6%) claiming it violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the Medicare program.

The complaint alleges that PMC routinely dispensed Schedule II controlled drugs in non-emergency situations without first obtaining a written prescription from a treating physician, then knowingly submitted false claims to Medicare for the improperly dispensed Schedule II drugs.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs